Oct 29 2014 Relmada Therapeutics Adds $15 Million in Capital to Expedite Development of Pain Treatment Drugs View
Oct 16 2014 Relmada Therapeutics Reinforces Balance Sheet With $15.2 Million From Exercise Of Warrants View
Oct 09 2014 New Report Initiates Coverage on New Public Biopharmaceutical Company, Relmada Therapeutics, Inc. View
Sep 18 2014 Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development View
Sep 16 2014 Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER View
Sep 10 2014 Relmada Announces The Filing Of Clinical Trial Application In Canada For d-methadone View
Sep 03 2014 Relmada Therapeutics to Present at the 16th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th, 2014 View
